Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPS study of pamidronate for pain in sternocostoclavicular hyperostosis
NL-OMON60103Phase 3Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sternocostoclavicular hyperostosis (SCCH) and Chronic nonbacterial osteomyelitis (CRMO) comparing Pamidronate disodium with Placebo (2 arms). Started Dec 2020; status: recruiting.
02
Drugs
pamidronate
03
Conditions
sternocostoclavicular hyperostosis (SCCH)Chronic nonbacterial osteomyelitis (CRMO)
Beyond the preview
Go deeper on NL-OMON60103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60103.